Literature DB >> 17959777

Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting.

J Alexandra Rowe1, Ian G Handel, Mahamadou A Thera, Anne-Marie Deans, Kirsten E Lyke, Abdoulaye Koné, Dapa A Diallo, Ahmed Raza, Oscar Kai, Kevin Marsh, Christopher V Plowe, Ogobara K Doumbo, Joann M Moulds.   

Abstract

Malaria has been a major selective force on the human population, and several erythrocyte polymorphisms have evolved that confer resistance to severe malaria. Plasmodium falciparum rosetting, a parasite virulence phenotype associated with severe malaria, is reduced in blood group O erythrocytes compared with groups A, B, and AB, but the contribution of the ABO blood group system to protection against severe malaria has received little attention. We hypothesized that blood group O may confer resistance to severe falciparum malaria through the mechanism of reduced rosetting. In a matched case-control study of 567 Malian children, we found that group O was present in only 21% of severe malaria cases compared with 44-45% of uncomplicated malaria controls and healthy controls. Group O was associated with a 66% reduction in the odds of developing severe malaria compared with the non-O blood groups (odds ratio 0.34, 95% confidence interval 0.19-0.61, P < 0.0005, severe cases versus uncomplicated malaria controls). In the same sample set, P. falciparum rosetting was reduced in parasite isolates from group O children compared with isolates from the non-O blood groups (P = 0.003, Kruskal-Wallis test). Statistical analysis indicated a significant interaction between host ABO blood group and parasite rosette frequency that supports the hypothesis that the protective effect of group O operates through the mechanism of reduced P. falciparum rosetting. This work provides insights into malaria pathogenesis and suggests that the selective pressure imposed by malaria may contribute to the variable global distribution of ABO blood groups in the human population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17959777      PMCID: PMC2077280          DOI: 10.1073/pnas.0705390104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

2.  Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S.

Authors:  A Agarwal; A Guindo; Y Cissoko; J G Taylor; D Coulibaly; A Koné; K Kayentao; A Djimde; C V Plowe; O Doumbo; T E Wellems; D Diallo
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

3.  Blood group and susceptibility to disease caused by Escherichia coli O157.

Authors:  C Caroline Blackwell; Stephanie Dundas; Valerie S James; Doris A C Mackenzie; Jan M Braun; Abdulhamid M Alkout; W T Andrew Todd; Robert A Elton; Donald M Weir
Journal:  J Infect Dis       Date:  2002-01-08       Impact factor: 5.226

4.  Haemoglobin C protects against clinical Plasmodium falciparum malaria.

Authors:  D Modiano; G Luoni; B S Sirima; J Simporé; F Verra; A Konaté; E Rastrelli; A Olivieri; C Calissano; G M Paganotti; L D'Urbano; I Sanou; A Sawadogo; G Modiano; M Coluzzi
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

5.  Norwalk virus infection and disease is associated with ABO histo-blood group type.

Authors:  Anne M Hutson; Robert L Atmar; David Y Graham; Mary K Estes
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

6.  CR1 Knops blood group alleles are not associated with severe malaria in the Gambia.

Authors:  P A Zimmerman; J Fitness; J M Moulds; D T McNamara; L J Kasehagen; J Alexandra Rowe; A V S Hill
Journal:  Genes Immun       Date:  2003-07       Impact factor: 2.676

Review 7.  Malaria and the red cell.

Authors:  David J Weatherall; Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo; Climent Casals-Pascual; David J Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

8.  A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria.

Authors:  Ian A Cockburn; Margaret J Mackinnon; Angela O'Donnell; Stephen J Allen; Joann M Moulds; Moses Baisor; Moses Bockarie; John C Reeder; J Alexandra Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

9.  Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria.

Authors:  Kirsten E Lyke; Dapa A Diallo; Alassane Dicko; Abdoulaye Kone; Drissa Coulibaly; Ando Guindo; Yacouba Cissoko; Lansana Sangare; Seydou Coulibaly; Blaise Dakouo; Terrie E Taylor; Ogobara K Doumbo; Christopher V Plowe
Journal:  Am J Trop Med Hyg       Date:  2003-09       Impact factor: 2.345

10.  Identification of the Kna/Knb polymorphism and a method for Knops genotyping.

Authors:  J M Moulds; B J Thomas; O Doumbo; D A Diallo; K E Lyke; C V Plowe; J A Rowe; D J Birmingham
Journal:  Transfusion       Date:  2004-02       Impact factor: 3.157

View more
  110 in total

1.  ABO blood group and the risk of placental malaria in sub-Saharan Africa.

Authors:  Ayola A Adegnika; Adrian J F Luty; Martin P Grobusch; Michael Ramharter; Maria Yazdanbakhsh; Peter G Kremsner; Norbert G Schwarz
Journal:  Malar J       Date:  2011-04-22       Impact factor: 2.979

Review 2.  The hypothesis on function of glycosphingolipids and ABO blood groups revisited.

Authors:  Jerzy Kościelak
Journal:  Neurochem Res       Date:  2012-03-11       Impact factor: 3.996

Review 3.  Functional analysis of erythrocyte determinants of Plasmodium infection.

Authors:  Amy K Bei; Manoj T Duraisingh
Journal:  Int J Parasitol       Date:  2012-04-19       Impact factor: 3.981

4.  Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study.

Authors:  Tatiana M Lopera-Mesa; Saibou Doumbia; Drissa Konaté; Jennifer M Anderson; Mory Doumbouya; Abdoul S Keita; Seidina A S Diakité; Karim Traoré; Michael A Krause; Ababacar Diouf; Samuel E Moretz; Gregory S Tullo; Kazutoyo Miura; Wenjuan Gu; Michael P Fay; Steve M Taylor; Carole A Long; Mahamadou Diakité; Rick M Fairhurst
Journal:  Lancet Haematol       Date:  2015-03-24       Impact factor: 18.959

Review 5.  Population genetics of malaria resistance in humans.

Authors:  P W Hedrick
Journal:  Heredity (Edinb)       Date:  2011-03-23       Impact factor: 3.821

6.  Evolutionary dynamics of the human ABO gene.

Authors:  Francesc Calafell; Francis Roubinet; Anna Ramírez-Soriano; Naruya Saitou; Jaume Bertranpetit; Antoine Blancher
Journal:  Hum Genet       Date:  2008-07-16       Impact factor: 4.132

7.  ABO blood type A is associated with increased risk of ARDS in whites following both major trauma and severe sepsis.

Authors:  John P Reilly; Nuala J Meyer; Michael G S Shashaty; Rui Feng; Paul N Lanken; Robert Gallop; Sandra Kaplan; Maximilian Herlim; Nathaniel L Oz; Isabel Hiciano; Ana Campbell; Daniel N Holena; Muredach P Reilly; Jason D Christie
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

8.  Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes.

Authors:  Wenn-Chyau Lee; Benoit Malleret; Yee-Ling Lau; Marjorie Mauduit; Mun-Yik Fong; Jee Sun Cho; Rossarin Suwanarusk; Rou Zhang; Letusa Albrecht; Fabio T M Costa; Peter Preiser; Rose McGready; Laurent Renia; Francois Nosten; Bruce Russell
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

9.  Glycophorins, Blood Groups, and Protection from Severe Malaria.

Authors:  Samuel C Wassmer; Jane M Carlton
Journal:  Trends Parasitol       Date:  2015-11-21

10.  Parasite-host interaction in malaria: genetic clues and copy number variation.

Authors:  Imad Faik; Elisandra Grangeiro de Carvalho; Jürgen Fj Kun
Journal:  Genome Med       Date:  2009-09-02       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.